Nā huahana a me nā mea ho'onā a Macro & Micro-Test

ʻO ka PCR Fluorescence |Hoʻonui Isothermal |Colloidal Gold Chromatography |Fluorescence Immunochromatography

Nā huahana

  • ʻO Enterococcus kū'ē iā Vancomycin a me Gene kū'ē i ka lāʻau

    ʻO Enterococcus kū'ē iā Vancomycin a me Gene kū'ē i ka lāʻau

    Hoʻohana ʻia kēia kit no ka ʻike qualitative o vancomycin-resistant enterococcus (VRE) a me kāna mau genes kūʻē i ka lāʻau VanA a me VanB i loko o ka sputum kanaka, koko, mimi a i ʻole nā ​​kolone maʻemaʻe.

  • Kanaka Methylated NDRG4/SEPT9/SFRP2/BMP3/SDC2 Gene

    Kanaka Methylated NDRG4/SEPT9/SFRP2/BMP3/SDC2 Gene

    Hoʻolālā ʻia ka pahu no ka ʻike in vitro qualitative o nā genes methylated NDRG4/SEPT9/SFRP2/BMP3/SDC2 i loko o nā pūnaewele exfoliated intestinal i loko o nā mea hoʻohālike o ke kanaka.

  • ʻO ke kanaka CYP2C9 a me VKORC1 Gene Polymorphism

    ʻO ke kanaka CYP2C9 a me VKORC1 Gene Polymorphism

    Pili kēia kit i ka in vitro qualitative detection of polymorphism o CYP2C9*3 (rs1057910, 1075A>C) a me VKORC1 (rs9923231, -1639G>A) i loko o ka genomic DNA o ke kanaka holookoa koko samples.

  • Kanaka CYP2C19 Gene Polymorphism

    Kanaka CYP2C19 Gene Polymorphism

    Hoʻohana ʻia kēia pahu no ka ʻike in vitro qualitative o ka polymorphism o CYP2C19 genes CYP2C19*2 (rs4244285, c.681G>A), CYP2C19*3 (rs4986893, c.636G>A), CYP2C19*248 (rs4244285, c.681G>A), CYP2C19*3 (rs4986893, c.636G>A), CYP2C19*248 (rs4012,608). >T) i ka DNA genomic o nā laʻana koko holoʻokoʻa kanaka.

  • Staphylococcus Aureus a me ka Methicillin-Resistant Staphylococcus Aureus Nucleic Acid

    Staphylococcus Aureus a me ka Methicillin-Resistant Staphylococcus Aureus Nucleic Acid

    Hoʻohana ʻia kēia pahu no ka ʻike qualitative o staphylococcus aureus a me nā methicillin-resistant staphylococcus aureus nucleic acids i loko o nā laʻana sputum kanaka, nā ʻili a me nā mea maʻi maʻi palupalu, a me nā laʻana koko holoʻokoʻa in vitro.

  • Kanaka Leukocyte Antigen B27 Nucleic Acid

    Kanaka Leukocyte Antigen B27 Nucleic Acid

    Hoʻohana ʻia kēia pahu no ka ʻike qualitative o ka DNA i nā subtypes antigen leukocyte kanaka HLA-B*2702, HLA-B*2704 a me HLA-B*2705.

  • Fecal Occult Blood/Transferrin Hui

    Fecal Occult Blood/Transferrin Hui

    He mea kūpono kēia kit no ka ʻike in vitro qualitative o Human hemoglobin (Hb) a me Transferrin (Tf) i loko o nā laʻana kuʻekuʻe kanaka, a hoʻohana ʻia no ka ʻike kōkua o ke kahe ʻana o ka digestive tract.

  • Enterovirus 71 Nucleic Acid

    Enterovirus 71 Nucleic Acid

    Hoʻolālā ʻia kēia pahu no ka ʻike in vitro qualitative o Enterovirus 71 nucleic acid i loko o nā laʻana swab puʻu kanaka.

  • ʻO Enterovirus Universal Nucleic Acid i hoʻomaloʻo ʻia

    ʻO Enterovirus Universal Nucleic Acid i hoʻomaloʻo ʻia

    Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitative o enterovirus universal nucleic acid i loko o ka puʻu ʻāʻī a me nā hōʻailona wai o ka herpes o nā mea maʻi me ka maʻi lima-wāwae-waha, a hāʻawi i kahi ala kōkua no ka hōʻoia ʻana o nā maʻi me ka maʻi lima-wāwae-waha.

  • Coxsackie Virus Type A16 Nucleic Acid

    Coxsackie Virus Type A16 Nucleic Acid

    Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitative o Coxsackie virus type A16 nucleic acid i loko o ka ʻāʻī ʻāʻī kanaka.

  • Monkeypox Virus Nucleic Acid

    Monkeypox Virus Nucleic Acid

    Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitative o ka monkeypox virus nucleic acid i loko o ka wai ʻūhū kanaka, nā nasopharyngeal swabs, nā ʻāʻī a me nā laʻana serum.

  • 18 Nā ʻano o ke kanaka papilloma virus nucleic acid kiʻekiʻe

    18 Nā ʻano o ke kanaka papilloma virus nucleic acid kiʻekiʻe

    He kūpono kēia pahu no ka ʻike in vitro qualitative o 18 mau ʻano o nā maʻi papilloma kanaka (HPV) (HPV16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 82) nā ʻāpana ʻakika nucleic kikoʻī i loko o ka mimi kāne / wahine a me nā pūnaewele exfoliated cervical wahine a me ka HPV 16/18 type.